Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Weijie Pharmaceutical, now primarily branded as Greatway Pharma, is a specialized Contract Development and Manufacturing Organization (CDMO) based in Wuxi, China. The company focuses on the development and large-scale manufacturing of high-potency active pharmaceutical ingredients (APIs) and advanced intermediates, particularly in the field of oncology. They are well-known for their expertise in complex small molecule synthesis, including proteasome inhibitors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Weijie Pharmaceutical.